Go Pro
NASDAQ:VRXA

Veraxa Biotech (VRXA) Stock Price, News & Analysis

Veraxa Biotech logo
$1.44 -0.02 (-1.23%)
As of 03:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Veraxa Biotech Stock (NASDAQ:VRXA)

Advanced

Key Stats

Today's Range
$1.43
$1.52
50-Day Range
N/A
52-Week Range
$1.27
$27.36
Volume
38,774 shs
Average Volume
528,889 shs
Market Capitalization
$45.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Veraxa Biotech AG is a biotechnology company focused on developing targeted therapies for cancer and other serious diseases. Its research is centered on antibody-drug conjugates and related drug-conjugate technologies designed to deliver potent therapeutic agents selectively to diseased cells.

The company’s approach combines tumor-targeting antibodies with drug payloads, with the goal of improving treatment precision while limiting exposure to healthy tissue. Veraxa’s development activities include advancing its proprietary technology platforms and evaluating potential therapeutic candidates through preclinical and clinical research.

Veraxa Biotech is headquartered in Germany and operates in the biopharmaceutical sector. Publicly available information about its specific product pipeline, commercial operations and leadership is limited.

AI Generated. May Contain Errors.

Receive VRXA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veraxa Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VRXA Stock News Headlines

See More Headlines

VRXA Stock Analysis - Frequently Asked Questions

Veraxa Biotech's stock was trading at $1.35 on August 31, 2026. Since then, VRXA shares have increased by 8.9% and is now trading at $1.47.

Shares of VRXA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:VRXA
CIK
2079109
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
31,620,000
Free Float
N/A
Market Cap
$45.82 million
Optionable
N/A
Beta
0.18
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:VRXA) was last updated on 9/21/2026 by MarketBeat.com Staff.
From Our Partners